Ansh Enterprises

 100mg tablet contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. This tablet is used in treating adults and children with chronic myeloid leukemia (CML- it is a form of leukemia in which certain abnormal white blood cells start growing out of control). It is also indicated to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL). It is also used to treat certain types of gastrointestinal stromal tumors (GIST, a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). 

Imatib 100mg tablet is also used to treat myelodysplastic/myeloproliferative diseases (MDS/MPD); these are a group of blood diseases in which some blood cells start growing out of control. They also treat hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL); these are blood diseases in which some blood cells (eosinophils) start growing out of control. This medicine is also intended to treat dermatofibrosarcoma protuberans (DFSP), a cancer of the tissue beneath the skin in which some cells start growing abnormally. It works to inhibit the growth of these abnormal blood cells.  

Do not take Imatib 100mg tablet if you are allergic to imatinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have kidney, heart, or liver problems, if you have thyroid problems, or if your thyroid gland has been removed. Notify your doctor if you ever had or have a hepatitis B infection because this medicine could cause the hepatitis B to become active again. Report any symptoms of bruising, bleeding, fever, fatigue, and confusion when taking this medicine. This medicine may cause fertility problems.  

Uses of Imatib 100mg Tablet

• Chronic myeloid leukemia (CML)
• Philadelphia chromosome positive acute lymphoblastic leukemia (ph-positive ALL)
• Myelodysplastic/myeloproliferative diseases (MDS/MPD)
• Hypereosinophilic syndrome (HES)
• Chronic eosinophilic leukemia (CEL)
• Dermatofibrosarcoma protuberans (DFSP)
• Gastrointestinal stromal tumors (GIST)